Brief: Bellicum Pharma Says On April 4, Entered Into A Supply Agreement With Miltenyi Biotec GMBH
10/04/2019 21:25
April 10 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS SAYS ON APRIL 4, ENTERED INTO A
SUPPLY
AGREEMENT MADE EFFECTIVE AS OF MARCH 27, WITH MILTENYI BIOTEC
GMBH - SEC FILING
* BELLICUM PHARMACEUTICALS INC - PURSUANT TO AGREEMENT,
COMPANY
AGREED TO MAKE AN AGGREGATE EUR2 MILLION UPFRONT PAYMENT TO
MILTENYI IN TWO INSTALLMENTS
* BELLICUM PHARMACEUTICALS - CO ALSO AGREED TO PAY MILTENYI
UP TO
AGGREGATE OF EUR500 THOUSAND IN MILESTONE PAYMENTS
* BELLICUM PHARMACEUTICALS INC - COMPANY AGREED TO MAKE
MINIMUM
ANNUAL PURCHASES UNDER AGREEMENT
* BELLICUM PHARMACEUTICALS INC - AGREEMENT HAS AN INITIAL
TERM OF
10 YEARS FROM EFFECTIVE DATE
* BELLICUM PHARMACEUTICALS INC - COMPANY ALSO HAS OPTION TO
RENEW
AGREEMENT FOR SUCCESSIVE FIVE YEAR TERMS
* BELLICUM PHARMACEUTICALS INC - COMPANY MAY TERMINATE
AGREEMENT
UPON 90 DAYS WRITTEN NOTICE TO MILTENYI
Source text: [http://bit.ly/2GgcvE0]
Further company coverage: BLCM.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview